A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Who Are 4 Months or Older
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The main aims of the study are to check for side effects from teduglutide.
Participants will receive a daily injection of teduglutide just under the skin (subcutaneous)
for 24 weeks. Then they are followed up for another 4 weeks. Participants may be able to
repeat this treatment if they meet specific criteria. The study doctors will check for side
effects from teduglutide until it becomes commercially available.